Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1A fixed-dose combination of 95 mg clarithromycin, 45 mg rifabutin, and 10 mg clofazimine
(D00276)		3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: Clarithromycin (D00276),
Clofazimine ,
Rifabutin 💬 		--1件: 96 💬
2Biaxin ( clarithromycin)
(D00276)		1件: Clarithromycin1件: Clarithromycin (D00276) 💬 --1件: 299 💬
3Clarithromycin
(D00276)		1件: Clarithromycin1件: Clarithromycin (D00276) 💬 --10件: 6, 46, 63, 84, 96, 97, 222, 223, 228, 299 💬
4Clarithromycin (Not used as of 4/2020)
(D00276)		1件: Clarithromycin1件: Clarithromycin (D00276) 💬 --1件: 6 💬
5Clarithromycin 15 mg/kg/day in 2 divided doses for 14 days.
(D00276)		1件: Clarithromycin1件: Clarithromycin (D00276) 💬 --1件: 63 💬
6Lansoprazole, amoxicillin, clarithromycin
(D00276)		3件: Amoxicillin,
Clarithromycin,
Lansoprazole		5件: Amoxicillin ,
Clarithromycin (D00276),
Lansoprazole ,
Amoxicillin sodium ,
Amoxicillin 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬2件: 222, 223 💬
7Lansoprazole, clarithromycin, amoxycillin
(D00276)		2件: Clarithromycin,
Lansoprazole		2件: Clarithromycin (D00276),
Lansoprazole 💬 		2件: ATP4A,
ATP4B 💬 		3件: Collecting duct acid secretion, Gastric acid secretion, Oxidative phosphorylation 💬1件: 63 💬
8Rifabutin, Clarithromycin, and Clofazimine
(D00276)		3件: Clarithromycin,
Clofazimine,
Rifabutin		3件: Clarithromycin (D00276),
Clofazimine ,
Rifabutin 💬 		--1件: 96 💬